A PHASED APPROACH TO DRUG DEVELOPMENT - COMMENTARY

被引：0

|

作者：

KAPLAN, SA

机构：

来源：

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1989年 / 17卷 / 04期

关键词：

D O I：

10.1007/BF01061461

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：521 / 523

页数：3

相关论文

共 50 条

[31] Texaphyrins: a new approach to drug development
Mody, TD
Sessler, JL
JOURNAL OF PORPHYRINS AND PHTHALOCYANINES, 2001, 5 (02) : 134 - 142
[32] DRUG DEVELOPMENT - A SYSTEMATIC-APPROACH
ZEELEN, FJ
CHEMTECH, 1983, 13 (07) : 419 - 425
[33] The Seamless Approach to Drug Development in Oncology
Ratain, Mark J.
Clinical Advances in Hematology & Oncology, 2016, 14 (12) : 958 - 959
[34] Systems approach to drug development.
Mills, B.
CLINICAL CANCER RESEARCH, 2018, 24 (15) : 20 - 21
[35] One Step at a Time: A Phased Approach to Behavioral Treatment Development in Pulmonary Rehabilitation
Janaudis-Ferreira, Tania
Ross, Bryan
Bourbeau, Jean
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (05) : 774 - 775
[36] Complex traits, genes, polymorphisms and the drug discovery/development process - Commentary
Kola, I
CURRENT OPINION IN BIOTECHNOLOGY, 1999, 10 (06) : 589 - 592
[37] NIA Commentary: Translational Issues in Alzheimer’s Disease Drug Development
Neil S Buckholtz
Laurie M Ryan
Suzana Petanceska
Lorenzo M Refolo
Neuropsychopharmacology, 2012, 37 : 284 - 286
[38] NIA Commentary: Translational Issues in Alzheimer's Disease Drug Development
Buckholtz, Neil S.
Ryan, Laurie M.
Petanceska, Suzana
Refolo, Lorenzo M.
NEUROPSYCHOPHARMACOLOGY, 2012, 37 (01) : 284 - 286
[39] Commentary on ACCP position statement on the use of microdosing in the drug development process
Rowland, Malcolm
JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (12): : 1595 - 1596
[40] COMMENTARY: PEDIATRIC ANTIFUNGAL DRUG DEVELOPMENT LESSONS LEARNED AND RECOMMENDATIONS FOR THE FUTURE
Watt, Kevin M.
Cohen-Wolkowiez, Michael
Ward, Robert M.
Benjamin, Daniel K., Jr.
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (06) : 635 - 637

← 1 2 3 4 5 →